Dreyer Scott Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
22
Insider Sells Sum
$8.69M

Insider Activity of Dreyer Scott

According to the SEC Form 4 filings, Dreyer Scott, being in a position of

  1. EVP & Chief Commercial Officer at Collegium Pharmaceutical, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 67576 shares for $2.87M,
    over all time since 2019-07-11, has bought 0 shares, and sold 383916 shares for $12.36M.

Biography of Dreyer Scott

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$2,867,2922100

Comparison of Insiders on Amount of Buys and Sells

2026-03-03SaleCollegium Pharmaceutical, Inc.
COLL
EVP & Chief Commercial Officer
49,976
0.1536%
$40.41$2.02M-16.54%
2025-12-08SaleCollegium Pharmaceutical, Inc.
COLL
EVP & Chief Commercial Officer
17,600
0.056%
$48.17$847,855-27.53%
2025-08-18SaleCollegium Pharmaceutical, Inc.
COLL
EVP & Chief Commercial Officer
16,389
0.052%
$38.21$626,171-6.23%
2025-08-13SaleCollegium Pharmaceutical, Inc.
COLL
EVP & Chief Commercial Officer
4,861
0.0155%
$38.03$184,881-5.31%
2025-03-21SaleCollegium Pharmaceutical, Inc.
COLL
EVP & Chief Commercial Officer
18,881
0.0599%
$30.03$566,983+17.89%
2025-03-20SaleCollegium Pharmaceutical, Inc.
COLL
EVP & Chief Commercial Officer
1,927
0.0061%
$30.00$57,811+18.31%
2025-03-14SaleCollegium Pharmaceutical, Inc.
COLL
EVP & Chief Commercial Officer
2,255
0.0073%
$30.00$67,661+19.37%
2025-03-11SaleCollegium Pharmaceutical, Inc.
COLL
EVP & Chief Commercial Officer
15,387
0.0489%
$30.00$461,672+17.24%
2025-03-07SaleCollegium Pharmaceutical, Inc.
COLL
EVP & Chief Commercial Officer
2,348
0.0077%
$30.00$70,446+20.81%
2025-03-06SaleCollegium Pharmaceutical, Inc.
COLL
EVP & Chief Commercial Officer
15,387
0.0491%
$30.00$461,672+17.18%
2025-03-06SaleCollegium Pharmaceutical, Inc.
COLL
EVP & Chief Commercial Officer
3,295
0.0105%
$30.00$98,854+17.18%
2024-05-24SaleCollegium Pharmaceutical, Inc.
COLL
EVP & Chief Commercial Officer
56,807
0.1745%
$33.98$1.93M-7.42%
2024-05-23SaleCollegium Pharmaceutical, Inc.
COLL
EVP & Chief Commercial Officer
51,209
0.1565%
$33.82$1.73M-6.17%
2024-02-26SaleCollegium Pharmaceutical, Inc.
COLL
EVP & Chief Commercial Officer
10,000
0.0312%
$36.43$364,270-6.32%
2024-01-16SaleCollegium Pharmaceutical, Inc.
COLL
EVP & Chief Commercial Officer
23,560
0.0725%
$32.28$760,519+6.04%
2023-03-01SaleCollegium Pharmaceutical, Inc.
COLL
EVP & Chief Commercial Officer
13,324
0.0395%
$26.70$355,751-12.24%
2023-01-09SaleCollegium Pharmaceutical, Inc.
COLL
EVP & Chief Commercial Officer
17,834
0.0521%
$27.39$488,554-15.77%
2022-02-18SaleCollegium Pharmaceutical, Inc.
COLL
EVP & Chief Commercial Officer
10,559
0.0312%
$21.61$228,180-16.62%
2021-12-15SaleCollegium Pharmaceutical, Inc.
COLL
EVP & Chief Commercial Officer
5,693
0.016%
$18.33$104,353-3.57%
2021-02-11SaleCollegium Pharmaceutical, Inc.
COLL
EVP & Chief Commercial Officer
7,898
0.0227%
$25.21$199,132-16.24%
Total: 26
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.